Featured Research

from universities, journals, and other organizations

How to divide and conquer 'social network' of cells

Date:
January 11, 2010
Source:
University of Montreal
Summary:
On Noah's Ark animals came in twos: male and female. In human bodies trillions of cells are coupled, too, and so are the molecules from which they are composed. Yet these don't come in twos, they are regrouped into indistinguishable clusters. Because these complex cell networks are the backbone of life -- and illness -- scientists have long searched for ways to splice cell clusters down to their original pairs.

On Noah's Ark animals came in twos: male and female. In human bodies trillions of cells are coupled, too, and so are the molecules from which they are composed. Yet these don't come in twos, they are regrouped into indistinguishable clusters. Because these complex cell networks are the backbone of life -- and illness -- scientists have long searched for ways to splice cell clusters down to their original pairs.

According to a new study in the journal Nature Methods, Université de Montréal scientists Stephen Michnick and Po Hien Ear have managed the feat of dividing cell networks down to their genesis. The discovery could have applications for diseases such as cancer, where blood-thirsty cells could be decoupled to curb their multiplication in the human body.

"We have provided a simple way to decouple one cellular network from another," says Dr. Michnick, a Université de Montréal biochemistry professor and Canada Research Chair in Integrative Genomics. "Once decoupled, we could clearly distinguish what one network was doing versus another."

As part of their study, the researchers reproduced gene networks using baker's yeast -- a cellular organism proven to resemble the critical functions of human cells. "We cut out relationships between cells to see which are crucial and which are not," explains Dr. Michnick. "We found that de-coupling cells permitted growth regulation. One way to attack cancer would be to find molecules that decouple other networks (as we did), slow down its growth and weaken the illness."


Story Source:

The above story is based on materials provided by University of Montreal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ear et al. A general life-death selection strategy for dissecting protein functions. Nature Methods, 2009; 6 (11): 813 DOI: 10.1038/nmeth.1389

Cite This Page:

University of Montreal. "How to divide and conquer 'social network' of cells." ScienceDaily. ScienceDaily, 11 January 2010. <www.sciencedaily.com/releases/2009/11/091109121211.htm>.
University of Montreal. (2010, January 11). How to divide and conquer 'social network' of cells. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/11/091109121211.htm
University of Montreal. "How to divide and conquer 'social network' of cells." ScienceDaily. www.sciencedaily.com/releases/2009/11/091109121211.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins